BRIEF published on 07/29/2024 at 08:34, 3 months 23 days ago New paragon Lead Plant Inaugurated in China Automotive Industry Electromobility Paragon AG Kunshan Plant China Expansion
PRESS RELEASE published on 07/29/2024 at 08:29, 3 months 23 days ago New paragon lead plant inaugurated in China paragon GmbH & Co. KGaA inaugurates new lead plant in Kunshan, China, expanding production and office space. The modern facility strengthens partnerships with Chinese car manufacturers Automotive Industry China Paragon GmbH Lead Plant Kunshan
BRIEF published on 07/25/2024 at 08:12, 3 months 27 days ago Paragon Announces Preliminary Half-Year Figures - Operating Profitability and Cash Flow Improved EBITDA Cash Flow Profitability Half-year Results Paragon
PRESS RELEASE published on 07/25/2024 at 08:07, 3 months 27 days ago paragon announces preliminary half-year figures - operating profitability and cash flow improved paragon GmbH & Co. KGaA announces preliminary half-year figures with improved operating profitability and cash flow. Earnings and EBITDA ratios show growth despite sales decline EBITDA Cash Flow Profitability Half-year Results Paragon GmbH
BRIEF published on 05/07/2024 at 07:35, 6 months 14 days ago Paragon GmbH Reports Strong Start to 2024 Despite Challenges Revenue Forecast EBITDA Growth Q1 2024 Financial Results Paragon GmbH Operational Expansion
PRESS RELEASE published on 05/07/2024 at 07:30, 6 months 14 days ago paragon enters the new year with optimism - positive start to 2024 paragon GmbH & Co. KGaA starts 2024 optimistically with positive revenue and EBITDA growth. Company confirms forecast for the year EBITDA Revenue Growth Paragon GmbH & Co. KGaA Forecast Confirmation 2024 Financial Results
BRIEF published on 04/25/2024 at 08:05, 6 months 26 days ago Paragon AG Releases 2023 Annual Financial Report, Confirms Forecast EBITDA Paragon GmbH & Co. KGaA Debt Reduction Financial Results 2023 2024 Forecast
PRESS RELEASE published on 04/25/2024 at 08:00, 6 months 26 days ago Audited consolidated financial statements for 2023 confirm communicated forecast paragon GmbH & Co. KGaA's audited consolidated financial statements for 2023 confirm communicated forecast of stable sales and improved earnings. Debt reduction and positive outlook for 2024 highlighted 2024 Outlook Forecast Paragon GmbH & Co. KGaA Debt Reduction Audited Financial Statements
PRESS RELEASE published on 01/26/2024 at 15:24, 9 months 25 days ago paragon founder bundles shares in family holding paragon founder Klaus Dieter Frers transfers 49.3% shares to Frers Family Office GmbH, making it the largest shareholder, exempted from mandatory offer by BaFin. paragon GmbH & Co. KGaA is a global supplier to the automotive industry. Paragon GmbH & Co. KGaA Klaus Dieter Frers Frers Family Office GmbH Shareholder Structure BaFin Exemption
Published on 11/21/2024 at 14:00, 13 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 13 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 13 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 43 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 38 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 58 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 15 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 53 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
